BioMatrix Holdings, L.L.C.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2016 | $80 M | No. 1 | $50 to $250 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
BioMatrix Holdings, L.L.C. chose not to state its revenue in its newest notice of a funding round (Dec 2016).
SEC Form D · Dec 2016
The industry group it chose in its notices: Other Health Care.
SEC Form D · Dec 2016
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of BioMatrix Holdings, L.L.C. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Bruce Morgan Greenberg | Chief Executive Officer and Manager | Dec 2016 |
| Darrin Peter Carrico | Senior Vice President of Digital Health & Managed Care | Dec 2016 |
| David Peter Mccormick | Chief Clinical Officer | Dec 2016 |
| Joseph Peter Ziegler | Chief Financial Officer and Secretary | Dec 2016 |
| Saverio Peter Rafanelli | President and Chief Operating Officer | Dec 2016 |
| Todd Peter Krasinsky | Senior Vice President of Transplant Therapy | Dec 2016 |
| Bruce Morgan Greenberg | Chief Executive Officer and Manager | Dec 2016 |
| Daniel Morgan Jinich | Manager | Dec 2016 |
| Joe Morgan Davis | Manager | Dec 2016 |
| John Morgan Barr | Manager | Dec 2016 |
| L. Peter Smith | Manager | Dec 2016 |
| Pat Morgan Keefe | Manager | Dec 2016 |
| Tracy Morgan Finn | Manager and Executive Chairman | Dec 2016 |